全球液體添加劑成長機會

Global Liquid Dosage Excipients Growth Opportunities

出版日期: 2023年09月12日 | 出版商:

Frost & Sullivan | 英文 82 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄

對以患者為中心的腸外製劑的需求推動了成長潛力

液體給藥輔料全球研究分析了2022年至2030年北美、歐洲、亞太、拉丁美洲和中東非洲等關鍵區域市場的口服液和注射用輔料市場的成長情況，評估機會。口服溶液輔料市場提供各個細分市場的定性和定量分析，例如甜味劑、pH 調節劑/緩衝劑、潤濕劑/增溶劑等（螯合劑、防腐劑、調味劑等）。在口服液體製劑領域，用於治療兒童和老年人各種疾病的新藥認證數量不斷增加可能會在預測期內推動需求。全球腸胃外輔料市場的研究領域包括增溶劑、緩衝劑、防腐劑及其他（補劑、螯合劑、抗氧化劑、填充劑等）。治療癌症、罕見疾病和心血管疾病等疾病的生技藥品的需求將成為預測期內腸外輔料市場的主要成長要素。

分析範圍
分割
市場定義 - 藥用輔料
市場定義
市場定義 - 其他關鍵定義
主要競爭
全球醫藥市場概況
全球醫藥市場趨勢
促進因素
成長促進因素分析
成長抑制因素
生長抑制分析
價值鏈
成長指標
預測假設
收益預測
收益預測分析
按類型分類的收益預測
地區收益預測
按類型和地區分類的收益預測分析
競爭環境
競爭生態系統
競爭基準化分析
市場活動 - 新產品發布、併購、合作夥伴關係、業務擴展（2020-2023）
價格趨勢和預測分析

成長機會分析－口服液體添加劑

成長指標
收益和預測
按類型分類的收益預測
地區收益預測
預測分析
按類型進行預測分析
區域預測分析

成長機會分析 - 腸外添加劑

成長指標
收益預測
按類型分類的收益預測
地區收益預測
預測分析
按類型進行預測分析
區域預測分析

成長機會宇宙

成長機會 1 - 新輔料開發需要獨立核准途徑
基於生長機會 2-mRNA 的療法
成長機會 3 - 有效兒童用的需求
成長機會 4 - 特用注射劑/學名藥的差異化能力

下一步

下一步
為什麼現在要霜凍？
附件清單
免責聲明

簡介目錄

Product Code: PEF5-88

Demand for Patient-centric Parenteral Formulation Accelerates Growth Potential

The global study on the liquid dosage excipients assesses growth opportunities in the oral liquid and parenteral excipients market from 2022 to 2030 across major regional markets, including North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. The oral liquid excipients market provides qualitative and quantitative analyses of different segments such as sweetening agents, pH modifiers and buffering agents, wetting/solubilizing agents, and others (e.g., chelating agents, preservatives, and flavors). The increase in new drug approvals in the oral liquid formulation space to treat various diseases in children and older adults will drive demand over the forecast period. The segments examined under the global parenteral excipients market include solubilizing agents, buffering agents, preservatives, and others (e.g., tonicity adjusters, chelating agents, antioxidants, and bulking agents). Demand for biologics drugs to treat diseases such as cancer, orphan diseases, and cardiovascular diseases will be the primary growth contributor in the parenteral excipients market during the forecast period.

Strategic Imperatives

Why is it Increasingly Difficult to Grow?
The Strategic Imperative 8™
The Impact of the Top 3 Strategic Imperatives on the Liquid Dosage Excipient Industry
Growth Opportunities Fuel the Growth Pipeline Engine™

Growth Opportunity Analysis

Scope of Analysis
Segmentation
Market Definitions-Pharmaceutical Excipients
Market Definitions
Market Definitions-Other Key Definitions
Key Competitors
Global Pharmaceutical Market Overview
Global Pharmaceutical Market Trends
Growth Drivers
Growth Drivers Analysis
Growth Restraints
Growth Restraint Analysis
Value Chain
Growth Metrics
Forecast Assumptions
Revenue Forecast
Revenue Forecast Analysis
Revenue Forecast by Type
Revenue Forecast by Region
Forecast Analysis by Type and Region
Competitive Environment
Competitive Ecosystem
Competitive Benchmarking
Market Activities-New Product Launches, M&As, Partnerships, and Expansions, 2020-2023
Pricing Trends and Forecast Analysis

Growth Opportunity Analysis-Oral Liquid Excipients

Growth Metrics
Revenue Forecast
Revenue Forecast by Type
Revenue Forecast by Region
Forecast Analysis
Forecast Analysis by Type
Forecast Analysis by Region

Growth Opportunity Analysis-Parenteral Excipients

Growth Metrics
Revenue Forecast
Revenue Forecast by Type
Revenue Forecast by Region
Forecast Analysis
Forecast Analysis by Type
Forecast Analysis by Region

Growth Opportunity Universe

Growth Opportunity 1-Need for an Independent Approval Pathway for Novel Excipient Development
Growth Opportunity 2-mRNA-based Therapeutics
Growth Opportunity 3-Need for Effective Pediatric Drug Delivery Solutions
Growth Opportunity 4-Differentiated Capabilities for Injectable Specialty Generics